Reseapro Health - Cancer Screening & Health Innovation
Saving Lives Through Early Detection
Cancer is one of India’s fastest-growing public-health challenges. Late detection continues to claim thousands of preventable lives each year, particularly in underserved rural and tribal communities that lack access to diagnostic infrastructure.
At Reseapro Scientific Services Pvt. Ltd., we are reshaping India’s early-detection ecosystem through technology-enabled, large-scale cancer-screening programs that emphasize affordability, accessibility, and accuracy.
Our goal is simple yet transformative — to ensure that every individual, regardless of geography or income, has access to timely cancer screening and diagnosis.
From Awareness to Action
We envision a future where preventive health screening becomes part of every community’s healthcare fabric.
Through partnerships with state health departments, CSR divisions of PSUs, and advanced diagnostic companies, Reseapro delivers comprehensive, evidence-based programs for Oral, Breast, and Cervical Cancer Screening— the top three cancers affecting Indian populations.
Each program combines mobile technology, AI-assisted diagnostics, and trained health-worker networks to reach remote regions where hospital-based screening is not viable.
Reseapro’s Integrated Health Innovation Model
Our health-innovation framework combines science, technology, and social engineering.
Community Outreach & Awareness
Local health campaigns to educate populations about early signs, risk factors, and available screening options.
Mobile Screening Units
Fully equipped vans with Oral, Breast, and Cervical-cancer screening devices and trained operators.
AI-Powered Diagnostics
Integration of machine-learning algorithms to detect malignancy indicators rapidly and accurately.
Data Integration & Monitoring
Cloud-based health dashboards for patient tracking, analytics, and follow-up coordination.
Referral & Continuum of Care
Linkages with tertiary hospitals and state health facilities for further diagnostic confirmation and treatment.
Core Focus Areas
Oral Cancer Screening
India contributes nearly one-third of global oral-cancer cases, primarily due to tobacco use and late diagnosis. Reseapro partners with Sascan Meditech to deploy OralScan, a non-invasive optical-imaging device that identifies pre-malignant lesions with high precision. Each device supports screening of over 100 individuals per day, making it ideal for high-density rural programs.
Breast Cancer Screening
Collaborating with C-MET Kerala and Niramai Health Analytix, Reseapro introduces thermal-imaging and wearable-sensor technologies for radiation-free breast screening. These tools detect early-stage abnormalities even in younger women, addressing the gap left by conventional mammography in resource-limited areas.
CSR-Funded Research Deployments
Using AI-enhanced visual-inspection (VIA/VILI) and liquid-biopsy-based HPV detection, our cervical-screening programs offer a quick, low-cost solution that can be administered by trained nurses in field conditions.
Technology Integration
All technologies are validated through multi-site clinical studies and compliant with ICMR and MoHFW guidelines.
| Technology Platform | Function / Application | Partner / Developer |
|---|---|---|
| OralScan | Optical fluorescence imaging for oral lesions | Sascan Meditech Pvt Ltd |
| ThermalytiX™ Smart Bra | AI-powered thermographic breast-screening | C-MET Kerala / Niramai |
| AI-VIA System | Automated cervical-lesion detection | Reseapro Health Tech Lab |
| Liquid Biopsy Kit | Non-invasive biomarker analysis | In-house R&D and partner labs |
Field Implementation and Impact
These initiatives generate both public-health impact and data-driven insights for policy formulation.
| Parameter | Impact(2024-25 Projection) |
|---|---|
| States Covered | Jharkhand, Chhattisgarh, Odisha, West Bengal |
| Screening Centres & Mobile Units | 120 static + 50 mobile centres |
| Individuals Screened Annually | >1 million across 3 cancer types |
| Referral Linkages Created | 300+ District & Sub-District Hospitals |
| CSR Partners Engaged | 10 PSUs & Private Corporations |
| Training Programs Conducted | 200+ health-worker workshops |
CSR and Public-Sector Partnerships
Reseapro’s cancer-screening programs are designed to align with:
- Schedule VII (Healthcare & Preventive Health) under the Companies Act 2013
- Ayushman Bharat Health and Wellness Mission
- National Cancer Grid and NPCDCS Frameworks
- State Health Mission Partnership Models
We have ongoing collaborations with Coal India, NTPC, OMC, MTDC and Vedanta Foundation to deploy cancer-screening initiatives as part of their CSR mandates.
Training and Capacity Building
Sustainable healthcare depends on local empowerment. Reseapro conducts intensive training modules for:
- Auxiliary Nurse Midwives (ANMs) and ASHA workers
- District Medical Officers and Public-Health Supervisors
- NGO and Community Volunteers
Each trainee receives hands-on experience in device operation, patient engagement, and data entry through our Reseapro Health Data Portal.
Research and Innovation Pipeline
Our ongoing R&D initiatives include:
- AI-based multimodal screening algorithms combining imaging and biomarker data.
- Low-cost disposable biopsy cartridges for point-of-care diagnostics.
- Population-level epidemiological dashboards for risk-mapping and predictive analytics.
- Integration of MXene-based biosensors for real-time biomarker detection.
These programs ensure that every innovation remains grounded in both clinical validity and field feasibility.
Sustainability and Social Impact
Reseapro’s cancer-screening initiatives directly contribute to:
- UN Sustainable Development Goal 3 (Good Health and Well-being)
- Goal 5 (Gender Equality) by empowering female health workers and beneficiaries
- Goal 9 (Industry, Innovation & Infrastructure)
Every project is measured not just by numbers screened, but by lives saved, awareness created, and health systems strengthened.
Partner With Us
We invite :
- Corporate CSR Programs seeking measurable health impact
- State Governments and Health Missions scaling population screening
- Diagnostic Start-ups and Tech Partners co-developing AI solutions
- NGOs and Community Foundations extending our reach
“Early detection saves lives. Innovation ensures it saves more.”
— Reseapro Health Innovation Team
